The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility

Abstract We describe the use of dronabinol in a patient with severe intestinal dysmotility. Dronabinol was an effective treatment for nausea, vomiting, and anorexia. Insurance coverage of dronabinol could improve care for many patients. Article type: Case Report Keywords: Gastroparesis, Intestinal dysmotility, Failure to thrive, Cannabinoids Authors: Grace H. Taylor, Steven D. Schwaitzberg License: © 2015 The Authors CC BY-NC-ND 4.0 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Article links: DOI: 10.1016/j.ijscr.2015.04.036  |  PubMed: 25974259